Faehling, M. http://orcid.org/0000-0002-2439-7538
Achenbach, J.
Staib, P.
Steffen, U.
Tessen, H. W.
Gaillard, V. E.
Brugger, W.
Funding for this research was provided by:
Roche Pharma AG
Article History
Received: 29 March 2018
Accepted: 19 April 2018
First Online: 23 April 2018
Compliance with ethical standards
:
: MF has performed clinical phase IB-IV trials sponsored by Roche, Boehringer Ingelheim, and AstraZeneca, and received honoraria from Roche, Boehringer Ingelheim, and AstraZeneca in the past. JA reports personal fees from AstraZeneca, Bristol-Myers Squibb (BMS), Boehringer Ingelheim, Novartis, and Roche outside the submitted work. US and HWT have nothing to disclose. PS reports grants, personal fees, and non-financial support from Roche and Celgene, and grants from Astra Zeneca during the conduct of the study. In addition, outside the submitted work, PS reports grants, personal fees, and non-financial support from Pfizer, Novartis, Amgen, grants from MSD and BMS, and grants and personal fees from Astellas. VG reports personal fees from Roche Pharma AG outside the submitted work. WB reports personal fees from Roche, Boehringer Ingelheim, Lilly, AstraZeneca, BMS, Merck, Novartis, and Pfizer outside the submitted work.
: The observation plan for this non-interventional study was approved by the local Ethics Committee (Landesärztekammer Baden-Württemberg, F-2010-038). The study was performed in accordance with the 1964 Declaration of Helsinki and its later amendments and Good Clinical Practice guidelines.
: This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the non-interventional study concerning collection and processing of their personal data.